Two Sigma Securities, LLC Aldeyra Therapeutics, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.47 - $6.06 $22,482 - $92,681	15,294 New	15,294 $53,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $113,725 - $158,723	22,387 New	22,387 $155,000
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $81,042 - $121,563	-13,507 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $96,439 - $133,043	13,507 New	13,507 $122,000
Q4 2017 Feb 14, 2018	SELL	$5.7 - $7.75 $289,149 - $393,142	-50,728 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $197,839 - $547,862	50,728	50,728 $365,000

116

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $318M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.